Neuberger Berman High Yield Strategies Stock Price, News & Analysis

Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) announced the final results of its rights offering that expired on May 17, 2022. The final subscription price was set at $8.60, equal to 87% of the Fund's net asset value per share on the expiration date. A total of 4,763,981 shares will be issued, generating gross proceeds of approximately $40.9 million. Shares are expected to be issued by May 25, 2022. Investors will receive refunds for any excess payments made during the offering.

Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) completed its transferable rights offering, which ran from April 19 to May 17, 2022. Each stockholder received one right per share held, requiring three rights to purchase additional shares at a final subscription price of $8.60, representing 87% of the share's net asset value. The offering is expected to result in approximately 4,811,400 shares issued and gross proceeds of $41.3 million. Final results will be announced later.

Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) announced the approval of a rights offering for its common stock, allowing shareholders to purchase additional shares at a discount. The record date is April 19, 2022, with an expiration date planned for May 17, 2022.

This initiative aims to enhance the Fund's assets for investment in non-investment-grade credit, potentially improving long-term returns, and is likely to maintain current distribution levels. The Offer is seen as a positive step to capitalize on market opportunities.

Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) has announced an early declaration for its regular monthly distribution of $0.0905 per share, payable on May 31, 2022. The record date is May 4, 2022 and the ex-date is May 3, 2022. The Fund aims to maintain this distribution level, dependent on factors such as income stability and expenses. Future distributions may include net investment income, capital gains, or return of capital. There are risks related to market performance and investment strategy that could impact future distributions.

Neuberger Berman High Yield Strategies Fund Inc. (NHS) declared a monthly distribution of $0.0905 per share, payable on April 29, 2022. The record date is April 18, 2022, with an ex-date of April 14, 2022. The Fund aims to maintain a stable distribution rate, which may consist of net investment income, capital gains, and return of capital. The ability to sustain this rate depends on income stability, leverage costs, and other fees. Risks include market declines and competition from other investment companies.

Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) declared a monthly distribution of $0.0905 per share, payable on March 31, 2022. The record date is March 15, 2022, and the ex-date is March 14, 2022. While the Fund aims to maintain this distribution level subject to market conditions, its ability to do so depends on income stability, leverage costs, and other fees. Future distributions may include net investment income, capital gains, and return of capital. The Fund manages $460 billion in assets as of December 31, 2021.

Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) declared a monthly distribution of $0.0905 per share, payable on February 28, 2022. The record date is February 15, 2022, with an ex-date of February 14, 2022. The fund aims to maintain a stable distribution policy, although future distributions may include net investment income, capital gains, or return of capital. The fund's ability to sustain this rate depends on income stability, leverage costs, and overall fees. Investors are cautioned that there is no guarantee of consistent distributions.

Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) has declared a monthly distribution of $0.0905 per share, payable on January 31, 2022. The record date for this distribution is January 18, 2022, with an ex-date of January 14, 2022. The Fund aims to maintain regular distributions, although the sustainability is dependent on various factors including investment income stability, leverage costs, and Fund expenses. Future distributions may include net investment income, capital gains, and return of capital.

Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) announced the impending retirements of Co-Portfolio Managers Russ Covode and Daniel Doyle, effective on or about June 30, 2022. Current Co-Portfolio Managers Joseph Lind and Christopher Kocinski, who bring an average of 19 years of experience, will continue managing the Fund. Kocinski will also become Co-Head of U.S. High Yield. The Fund is supported by a seasoned team with extensive industry expertise, ensuring continuity in investment processes.